Latest Hemostasis Stories
The growth of the global hemostasis market is driven by factors such as increasing development of high-throughput hemostasis analyzers and focus of key players on the development of technologically
Right now, options are limited for preventing heart attacks.
-Now Direct with Hemostasis and Critical Care Product Lines in All Major Markets Worldwide- BEDFORD, Mass., Feb.
RESEARCH TRIANGLE PARK, N.C., March 3, 2011 /PRNewswire/ -- Talecris Biotherapeutics, Inc. (TLCR) announced today that it has been granted orphan drug designation by the European Commission for the development of Plasmin (human) to treat acute peripheral arterial occlusion (aPAO).
ROCKVILLE, Md., Jan.
SOMERVILLE, N.J., Nov. 18, 2010 /PRNewswire/ -- Ethicon, Inc., a worldwide leader in surgical care, announced today that the company has submitted a Biologic License Application (BLA) to the U.S.
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).